Geneva, May 29 -- International Clinical Trials Registry received information related to the study (ChiCTR2600124906) titled 'Study on the efficacy of targeted therapy and immunotherapy for osteosarcoma based on organoids' on May 19.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: The Second Hospital of Jiaxing
Condition:
bone tumor
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-06-01
Target Sample Size: Observation group:100;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=323938
Disclaimer: Curated by HT Syndication....